Canada Life’s Tvardi Therapeutics TVRD Stock Holding History

Canada Life’s Portfolio TVRD Stock Details TVRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,675	Closed	-$295K	–	2309
2023 Q1	$295K	Sell	1,675 -26	-2%	-$8.71K	﹤0.01%	1813
2022 Q4	$658K	Buy	1,701 +84	+5%	+$31.9K	﹤0.01%	1649
2022 Q3	$545K	Buy	1,617 +491	+44%	+$178K	﹤0.01%	1664
2022 Q2	$369K	Buy	1,126 +124	+12%	+$43.5K	﹤0.01%	1728
2022 Q1	$449K	Hold	1,002	–	–	﹤0.01%	1736
2021 Q4	$439K	Hold	1,002	–	–	﹤0.01%	1733
2021 Q3	$560K	Hold	1,002	–	–	﹤0.01%	1707
2021 Q2	$514K	Buy	1,002 +904	+922%	+$573K	﹤0.01%	1737
2021 Q1	$76K	Hold	98	–	–	﹤0.01%	2172
2020 Q4	$54K	Hold	98	–	–	﹤0.01%	2251
2020 Q3	$45K	Hold	98	–	–	﹤0.01%	2207
2020 Q2	$60K	Hold	98	–	–	﹤0.01%	2177
2020 Q1	$47K	Hold	98	–	–	﹤0.01%	2147
2019 Q4	$57K	Buy	+98	New	+$68.8K	﹤0.01%	2221
2019 Q3	–	Sell	-69	Closed	-$54K	–	2340
2019 Q2	$54K	Sell	69 -104	-60%	-$73.1K	﹤0.01%	2421
2019 Q1	$122K	Buy	173 +98	+131%	+$58.7K	﹤0.01%	2005
2018 Q4	$34K	Hold	75	–	–	﹤0.01%	2475
2018 Q3	$65K	Hold	75	–	–	﹤0.01%	2328
2018 Q2	$52K	Hold	75	–	–	﹤0.01%	2398
2018 Q1	$33K	Hold	75	–	–	﹤0.01%	2444
2017 Q4	$33K	Hold	75	–	–	﹤0.01%	2442
2017 Q3	$36K	Hold	75	–	–	﹤0.01%	2410
2017 Q2	$41K	Buy	+75	New	+$47.6K	﹤0.01%	2376

Other funds holding TVRD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Canada Life's TVRD Position: Q2 2023 in Review

Canada Life sold out of Tvardi Therapeutics (TVRD) in Q2 2023, closing a stake of 1,675 shares — an estimated $295K sold.

Canada Life first reported a position in TVRD in Q2 2017 and held it in 23 quarters. The position peaked at $658K in Q4 2022. 136 funds tracked by Wall St. Rank hold TVRD as of Q2 2023.

Canada Life reported no remaining Tvardi Therapeutics position as of Q2 2023 after selling out during the quarter.
Canada Life sold 1,675 Tvardi Therapeutics shares in Q2 2023, an estimated $295K.
Canada Life first reported a position in Tvardi Therapeutics in Q2 2017 and held it in 23 quarters.
Canada Life's Tvardi Therapeutics position peaked at $658K in Q4 2022.
136 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2023.

Based on Canada Life's 13F filing for Q2 2023, filed 10 Aug 2023.